REASANZ Trademark

Trademark Overview


On Thursday, February 2, 2012, a trademark application was filed for REASANZ with the United States Patent and Trademark Office. The USPTO has given the REASANZ trademark a serial number of 85532094. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 21, 2015. This trademark is owned by Novartis AG. The REASANZ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceu...
reasanz

General Information


Serial Number85532094
Word MarkREASANZ
Filing DateThursday, February 2, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 21, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2012

Trademark Statements


Goods and ServicesAnti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 7, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, September 21, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 21, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 24, 2015EXTENSION 5 GRANTED
Sunday, February 15, 2015EXTENSION 5 FILED
Sunday, February 15, 2015TEAS EXTENSION RECEIVED
Thursday, August 21, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 20, 2014EXTENSION 4 GRANTED
Sunday, August 17, 2014EXTENSION 4 FILED
Sunday, August 17, 2014TEAS EXTENSION RECEIVED
Saturday, March 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 28, 2014EXTENSION 3 GRANTED
Tuesday, February 18, 2014EXTENSION 3 FILED
Tuesday, February 18, 2014TEAS EXTENSION RECEIVED
Wednesday, September 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2013EXTENSION 2 GRANTED
Friday, August 9, 2013EXTENSION 2 FILED
Friday, August 9, 2013TEAS EXTENSION RECEIVED
Wednesday, February 27, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2013EXTENSION 1 GRANTED
Monday, February 18, 2013EXTENSION 1 FILED
Wednesday, February 27, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 18, 2013TEAS EXTENSION RECEIVED
Tuesday, August 21, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 26, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 15, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 14, 2012ASSIGNED TO EXAMINER
Tuesday, February 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 6, 2012NEW APPLICATION ENTERED IN TRAM